RenovoRx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of RenovoRx using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.10 | $-0.12 | 16.7 % |
Q2 | 2024-08-13 | $-0.10 | $-0.10 | 0.00 % |
Q1 | 2024-05-10 | $-0.07 | $-0.16 | 56.3 % |
Q4 | 2024-04-01 | $-0.30 | $-0.30 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
RenovoRx (RNXT) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.10, which beat the estimate of $-0.12.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.